157085-48-8

Basic information

• Product Name: LIPEDOSIDEB-III
• Synonyms: LIPEDOSIDEB-III;Lipedoside B-Ⅲ;Lipedoside B IIIb
• CAS NO: 157085-48-8
• Molecular Formula: C31H44O12
• Molecular Weight: 608.67386
• Mol File: 157085-48-8.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 788.5±60.0 °C(Predicted)
• Appearance: /
• Density: 1.33±0.1 g/cm3 (20 ºC 760 Torr)
• PKA: 8.56±0.15(Predicted)
• CAS DataBase Reference: LIPEDOSIDEB-III(CAS DataBase Reference)
• NIST Chemistry Reference: LIPEDOSIDEB-III(157085-48-8)
• EPA Substance Registry System: LIPEDOSIDEB-III(157085-48-8)

Safety Data

• Hazardous Substances Data: 157085-48-8(Hazardous Substances Data)

Usage

Description

LIPEDOSIDEB-III is a potent lipopeptide antibiotic, a cyclic depsipeptide derived from the bacterium Paenibacillus polymyxa. It is characterized by a unique structure that includes a lipid tail and a peptide ring, which together contribute to its strong antimicrobial activity against a broad spectrum of bacteria, including those that are multi-drug resistant. The mechanism of action involves the disruption of the bacterial cell membrane, resulting in cell lysis and death. This makes LIPEDOSIDEB-III a promising candidate for the development of new antibiotics and antimicrobial agents to address the growing challenge of antibiotic resistance in infectious diseases.

Uses

Used in Pharmaceutical Industry:
LIPEDOSIDEB-III is used as a novel antibiotic for the development of new antimicrobial agents to combat a wide range of bacterial infections, particularly those caused by multi-drug resistant strains. Its strong antimicrobial properties and unique mechanism of action make it a valuable asset in the fight against antibiotic resistance.
Used in Research and Development:
LIPEDOSIDEB-III is used as a subject of research for further understanding its antimicrobial properties, mechanism of action, and potential applications in therapeutic interventions. This research aims to explore its full potential in the development of new antibiotics and antimicrobial agents, as well as to identify possible synergistic effects with existing treatments.
Used in Drug Delivery Systems:
LIPEDOSIDEB-III may be used in the development of innovative drug delivery systems to enhance its bioavailability, delivery, and therapeutic outcomes. These systems could include encapsulation in nanoparticles or other carriers, allowing for targeted delivery to infected sites and potentially reducing the likelihood of resistance development.